JFS Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249 Buy
+10
New +$234 ﹤0.01% 2103
2023
Q4
Sell
-11
Closed -$223 1998
2023
Q3
$223 Sell
11
-18
-62% -$408 ﹤0.01% 1852
2023
Q2
$742 Sell
29
-6
-17% -$158 ﹤0.01% 1685
2023
Q1
$1.04K Buy
35
+2
+6% +$58 ﹤0.01% 1571
2022
Q4
$893 Buy
33
+4
+14% +$98 ﹤0.01% 1627
2022
Q3
$1K Buy
29
+18
+164% +$470 ﹤0.01% 1476
2022
Q2
$0 Sell
11
-13
-54% -$374 ﹤0.01% 1730
2022
Q1
$1K Buy
24
+13
+118% +$419 ﹤0.01% 1570
2021
Q4
$0 Buy
+11
New +$356 ﹤0.01% 1705
2020
Q1
Sell
-6
Closed 500
2019
Q4
$0 Buy
+6
New +$217 ﹤0.01% 515
2015
Q1
Sell
-2
Closed 507
2014
Q4
$0 Buy
+2
New +$79 ﹤0.01% 520

Other funds holding AVNS

JFS Wealth Advisors's AVNS Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in Avanos Medical (AVNS) in Q2 2026: 10 shares worth $249. The stake represents ﹤0.01% of the portfolio and ranks #2103 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in AVNS as recently as Q3 2023.

JFS Wealth Advisors first reported a position in AVNS in Q4 2014 and has held it in 11 quarters since. The position peaked at $1.04K in Q1 2023. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • JFS Wealth Advisors held 10 shares of Avanos Medical worth $249 as of Q2 2026.
  • Avanos Medical was a new JFS Wealth Advisors position in Q2 2026.
  • Avanos Medical made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2103 holding.
  • JFS Wealth Advisors first reported a position in Avanos Medical in Q4 2014 and has held it in 11 quarters since.
  • JFS Wealth Advisors's Avanos Medical position peaked at $1.04K in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.